MICROSCOPIC POLYANGIITIS (MPA)
Clinical trials for MICROSCOPIC POLYANGIITIS (MPA) explained in plain language.
Never miss a new study
Get alerted when new MICROSCOPIC POLYANGIITIS (MPA) trials appear
Sign up with your email to follow new studies for MICROSCOPIC POLYANGIITIS (MPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 4-Week steroid course be safer for vasculitis patients?
Disease control Recruiting nowThis study tests whether a shorter, lower-dose steroid treatment (4 weeks) combined with standard medications can safely control ANCA-associated vasculitis in people with severe kidney involvement. The goal is to reduce serious infections while still managing the disease. About 3…
Matched conditions: MICROSCOPIC POLYANGIITIS (MPA)
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
Skin biopsies could unlock secrets of rare blood vessel disease
Knowledge-focused Recruiting nowThis study looks at skin samples from 50 people with different types of vasculitis, a condition where blood vessels become inflamed. Researchers want to understand how the disease affects skin tissue at a molecular level. Participants must have an active skin lesion and a confirm…
Matched conditions: MICROSCOPIC POLYANGIITIS (MPA)
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated May 17, 2026 03:42 UTC
-
New study tracks pregnancy in women with rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows women with vasculitis (inflammation of blood vessels) who become pregnant. Researchers use online surveys to track disease activity and pregnancy outcomes across each trimester. The goal is to better understand how vasculitis affects pregnancy and what unique c…
Matched conditions: MICROSCOPIC POLYANGIITIS (MPA)
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 03:41 UTC